FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.264
+0.004 (1.42%)
At close: Dec 5, 2025, 4:00 PM EST
0.259
-0.005 (-1.78%)
After-hours: Dec 5, 2025, 7:55 PM EST
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $16.16 million as of December 5, 2025. Its market cap has decreased by -80.41% in one year.
Market Cap
16.16M
Enterprise Value
18.41M
1-Year Change
-80.41%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $16.16M, a decrease of -98.29%. That is a compound annual growth rate of -88.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 16.16M | -76.97% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.85B |
| Johnson & Johnson | 486.61B |
| AbbVie | 398.62B |
| UnitedHealth Group | 299.20B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.73B |
| Merck & Co. | 246.94B |
| Abbott Laboratories | 218.05B |